GSI Technology, Inc. Announces Second Quarter Fiscal 2026 Results

GSI Technology, Inc. Announces Second Quarter Fiscal 2026 Results Closed $50 Million Financing to Fund Gemini-II Platform Completion and Commence Plato Chip Design GlobeNewswire October 30, 2025 SUNNYVALE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — GSI Technology, Inc. (Nasdaq: GSIT) today reported financial results for its second fiscal quarter ended September 30, 2025. Summary Comments […]

BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025

(PinkSheets:BSEM),(Pinksheets:BSEM), POMPANO BEACH, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announces it will release its third quarter 2025 financial results on Thursday, November 13, 2025, and will host a conference call

Smackover Lithium Receives Key Final Integration Approval from the Arkansas Oil and Gas Commission for South West Arkansas Project

Smackover Lithium Receives Key Final Integration Approval from the Arkansas Oil and Gas Commission for South West Arkansas Project GlobeNewswire October 30, 2025 LEWISVILLE, Ark., Oct. 30, 2025 (GLOBE NEWSWIRE) — Smackover Lithium, a 55:45 owned Joint Venture (“JV”) between Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI) and Equinor (“Equinor”),

Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025

(NASDAQ:BNGO), SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, November 13, 2025, at 4:30 p.m. Eastern Time to report financial results for the third quarter 2025 and to highlight recent corporate progress. Conference Call & Webcast

Hub Group Reports Third Quarter 2025 Results

Hub Group Reports Third Quarter 2025 Results GlobeNewswire October 30, 2025 Highlights: GAAP diluted earnings per share (EPS) of $0.47 for the third quarter Third quarter revenue of $934 million Non-GAAP adjusted EPS of $0.49, which excludes adjusted items in the quarter Operating income of $39 million or 4.2% of revenue, adjusted operating income (non-GAAP)

zSpace Announces Third Quarter 2025 Earnings and Conference Call Information

(NASDAQ:ZSPC), SAN JOSE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — zSpace (Nasdaq: ZSPC) (“zSpace” or the “Company”), a global leader in immersive augmented reality (AR) learning solutions for education, announced today that it plans to release financial results for the third quarter ended September 30, 2025, on Thursday, November 13, 2025, after the close of

Synergy CHC Corp. Announces Third Quarter 2025 Earnings and Conference Call Information

(NASDAQ:SNYR), WESTBROOK, Maine, Oct. 30, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced that it plans to release financial results for the third quarter ended September 30, 2025, on Thursday, November 13, 2025, before the open of market trading. In conjunction

Inspirato to Announce Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

(NasdaqGM:ISPO), DENVER, Oct. 30, 2025 (GLOBE NEWSWIRE) — Inspirato Incorporated (“Inspirato” or the “Company”) (Nasdaq: ISPO), the premier luxury vacation club and property technology company, today announced plans to release financial and operating results for the quarter ended September 30, 2025, after market close on Tuesday, November 4, 2025. The Company will host a conference

Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025

Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025 GlobeNewswire October 30, 2025 CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report third quarter 2025

Legence Announces Extension and Repricing of Term Loan along with Increase and Extension of Revolving Credit Facility

Legence Announces Extension and Repricing of Term Loan along with Increase and Extension of Revolving Credit Facility GlobeNewswire October 30, 2025 SAN JOSE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced the amendment of its $798 million Term Loan Credit Facility, extending the maturity date by

Scroll to Top